1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Proteomics International Laboratories Limited
  6. Summary
    PIQ   AU000000PIQ0

PROTEOMICS INTERNATIONAL LABORATORIES LIMITED

(PIQ)
Delayed Australian Stock Exchange  -  05/20 01:50:28 am EDT
1.000 AUD    0.00%
05/11Proteomics International Laboratories Gets Funding for Kidney Disease Diagnostic Test; Shares Fall 6%
MT
04/11Proteomics International Laboratories Limited Announces New Clinical Advisory Board
CI
03/24Proteomics International Secures India Patent for Diabetic Kidney Disease Test; Shares Rise 4%
MT
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
0.95(c) 0.97(c) 1.01(c) 1(c) 1(c) Last
145 196 93 024 93 370 71 412 103 335 Volume
0.00% +2.11% +4.12% -0.99% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2020 2,73 M 1,92 M 1,92 M
Net income 2020 -1,74 M -1,23 M -1,23 M
Net cash position 2020 2,23 M 1,57 M 1,57 M
P/E ratio 2020 -21,1x
Yield 2020 -
Sales 2021 2,74 M 1,92 M 1,92 M
Net income 2021 -2,86 M -2,01 M -2,01 M
Net cash position 2021 5,54 M 3,89 M 3,89 M
P/E ratio 2021 -32,9x
Yield 2021 -
Capitalization 106 M 74,3 M 74,3 M
EV / Sales 2020 13,4x
EV / Sales 2021 33,5x
Nbr of Employees -
Free-Float 59,6%
More Financials
Company
Proteomics International Laboratories Ltd is an Australia-based medical technology company. The Company is engaged in predictive diagnostics and bio-analytical services. The Company specializes in proteomics, the study of the structure and function of proteins. The Company focuses on developing and commercializing diagnostic tests for chronic diseases. The Company operates in three business units unified by a... 
More about the company
All news about PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
05/11Proteomics International Laboratories Gets Funding for Kidney Disease Diagnostic Test; ..
MT
04/11Proteomics International Laboratories Limited Announces New Clinical Advisory Board
CI
03/24Proteomics International Secures India Patent for Diabetic Kidney Disease Test; Shares ..
MT
02/23Proteomics International Laboratories Limited Reports Earnings Results for the Half Yea..
CI
02/21Proteomics International Completes Pre-assessment Diagnostic Test Study for PromarkerD;..
MT
02/21Proteomics International Laboratories Limited Completes Pre-Assessment Phase of Promark..
CI
02/10PROTEOMICS INTERNATIONAL LABORATORIE : Application for quotation of securities - PIQ
PU
02/06Proteomics International Laboratories Identifies Protein Biomarkers for Asthma, COPD
MT
02/06Proteomics International Laboratories Limited Identifies Novel Biomarkers for Asthma an..
CI
02/03Proteomics International Laboratories Discovers Protein Biomarkers for Esophageal Cance..
MT
02/03Proteomics International Laboratories Ltd Announces It Has Successfully Completed Its V..
CI
01/26PROTEOMICS INTERNATIONAL LABORATORIE : December 2021 Quarterly Activities Report and Appen..
PU
2021Proteomics International Laboratories Secures Specialist Testing Contract for Pharmaceu..
MT
2021Proteomics International Laboratories Limited Secures Major Pharmacokinetic Testing Con..
CI
2021Proteomics International Laboratories Secures Tax Rebate from Federal R&D Incentive
MT
More news
News in other languages on PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
05/11Proteomics International Laboratories obtient un financement pour un test de diagnostic..
04/11Proteomics International Laboratories Limited annonce la création d'un nouveau conseil ..
03/24Proteomics International obtient un brevet indien pour le test de la maladie rénale dia..
02/23Proteomics International Laboratories Limited annonce ses résultats pour le semestre cl..
02/21Proteomics International achève l'étude du test de diagnostic de pré-évaluation pour Pr..
More news
Chart PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
Duration : Period :
Proteomics International Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Richard Lipscombe Managing Director & Director
Jacqueline Antoinette Christina Gray Chief Financial Officer
Neville Gardiner Non-Executive Chairman
Bringans Scott Manager-Research & Development
Ian Roger Moore Independent Non-Executive Director
Sector and Competitors